In another study with pancreatic cancer cells treated with gemcitabine in combination with ATR inhibitor ceralasertib (AZD6738), pharmacologic inhibition with the ATM inhibitor AZD0156 or knockout through CRISP-R of ATM led to replication catastrophe and cell death [73]. Here, ATM is linked to familial pancreatic carcinoma.